1. Fasshauer M, Blüher M (2015) Adipokines in health and disease. Trends Pharmacol Sci 36(7):461–470. https://doi.org/10.1016/j. tips.2015.04.014
2. Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Früh- beck G, Catalán V (2018) Adipokine dysregulation and adi- pose tissue inflammation in human obesity. Eur J Clin Invest 48(9):e12997. https://doi.org/10.1111/eci.12997
3. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772. https://doi.org/10.2337/ db06-1491
4. Ohn JH, Kwak SH, Cho YM, Lim S, Jang HC, Park KS et al (2016) 10-year trajectory of β-cell function and insulin sensitiv- ity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol 4(1):27–34. https://doi.org/10.1016/S2213-8587(15)00336-8
5. Hudish LI, Reusch JE, Sussel L (2019) β Cell dysfunction dur- ing progression of metabolic syndrome to type 2 diabetes. J Clin Invest 129(10):4001–4008. https://doi.org/10.1172/JCI129188
6. Good AL, Stoffers DA (2020) Stress-induced translational regula- tion mediated by RNA binding proteins: key links to β-cell fail- ure in diabetes. Diabetes 69(4):499–507. https://doi.org/10.2337/ dbi18-0068
7. Matsuda T, Kido Y, Asahara S, Kaisho T, Tanaka T, Hashimoto N et al (2010) Ablation of C/EBPβ alleviates ER stress and pan- creatic β cell failure through the GRP78 chaperone in mice. J Clin Invest 120(1):115–126. https://doi.org/10.1172/JCI39721
8. Shirakawa J, Togashi Y, Sakamoto E, Kaji M, Tajima K, Orime K et al (2013) Glucokinase activation ameliorates ER stress- induced apoptosis in pancreatic β-cells. Diabetes 62(10):3448– 3458. https://doi.org/10.2337/db13-0052
9. Westermark P, Andersson A, Westermark GT (2011) Islet amy- loid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 91(3):795–826. https://doi.org/10.1152/physrev.00042.2009
10. Tornovsky-Babeay S, Dadon D, Ziv O, Tzipilevich E, Kadosh T, Schyr-Ben Haroush R et al (2014) Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells. Cell Metab 19(1):109–121. https://doi.org/10.1016/j.cmet.2013.11.007
11. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56(9):2356–2370. https://doi.org/10. 2337/db06-1650
12. Tsuruta M, Iwashita M, Shinjo T, Matsunaga H, Yamashita A, Nishimura F (2018) Metabolic endotoxemia-activated mac- rophages promote pancreatic β cell death via IFNβ-Xaf1 path- way. Horm Metab Res 50(2):160–167. https://doi.org/10. 1055/s-0043-121467
13. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D et al (2001) Identification of XAF1 as an antagonist of XIAP anti Cas- pase activity. Nat Cell Biol 3(2):128–133. https://doi.org/10.1038/ 35055027
14. Hayashi M, Iwashita M, Nishimura Y, Shinjo T, Sano T, Yamash- ita A et al (2021) Adipose-specific C–C motif chemokine ligand (CCL) 19 overexpression drives the mice to both insulin resistance and weight gain. BMJ Open Diabetes Res Care 9(1):e001871. https://doi.org/10.1136/bmjdrc-2020-001871
15. Yamamotoya T, Nakatsu Y, Kushiyama A, Matsunaga Y, Ueda K, Inoue Y et al (2017) Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity. Sci rep 7(1):13026. https://doi.org/10.1038/s41598-017-13432-x
16. Wicksteed B, Brissova M, Yan W, Opland DM, Plank JL, Reinert RB et al (2010) Conditional gene targeting in mouse pancreatic β-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59(12):3090–3098. https://doi.org/10.2337/db10-0624
17. Lee MG, Huh JS, Chung SK, Lee JH, Byun DS, Ryu BK et al (2006) Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implica- tion for attenuated p53 response to apoptotic stresses. Oncogene 25(42):5807–5822. https://doi.org/10.1038/sj.onc.1209867
18. Park HS, Kim HZ, Park JS, Lee J, Lee SP, Kim H et al (2019) β-cell–derived angiopoietin-1 regulates insulin secretion and glucose homeostasis by stabilizing the islet microenvironment. Diabetes 68(4):774–786. https://doi.org/10.2337/db18-0864
19. Wang L, Luk CT, Cai EP, Schroer SA, Allister EM, Shi SY et al (2015) PTEN deletion in pancreatic α-cells protects against high- fat diet-induced hyperglucagonemia and insulin resistance. Dia- betes 64(1):147–157. https://doi.org/10.2337/db13-1715
20. Eguchi K, Manabe I, Oishi-Tanaka Y, Ohsugi M, Kono N, Ogata F et al (2012) Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metab 15(4):518–533. https://doi.org/10.1016/j.cmet.2012.01.023
21. Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA (2003) Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199(2):221–228. https:// doi.org/10.1002/path.1289
22. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV et al (1994) Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick trans- lation techniques. Lab Invest 71(2):219–225
23. Perry SW, Epstein LG, Gelbard HA (1997) Simultaneous in situ detection of apoptosis and necrosis in monolayer cultures by TUNEL and trypan blue staining. Biotechniques 22(6):1102– 1106. https://doi.org/10.2144/97226st01
24. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Tra- ganos F (1997) Cytometry in cell necrobiology: analysis of apop- tosis and accidental cell death (necrosis). Cytometry 27(1):1–20
25. Wang Z, York NW, Nichols CG, Remedi MS (2014) Pancreatic β cell dedifferentiation in diabetes and redifferentiation follow- ing insulin therapy. Cell Metab 19(5):872–882. https://doi.org/ 10.1016/j.cmet.2014.03.010
26. Chan CC, Damen MSMA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, Alarcon PC et al (2020) Type I interferon sens- ing unlocks dormant adipocyte inflammatory potential. Nat Com- mun 11(1):2745. https://doi.org/10.1038/s41467-020-16571-4
27. Jeffrey KD, Alejandro EU, Luciani DS, Kalynyak TB, Hu X, Li H et al (2008) Carboxypeptidase E mediates palmitate-induced β-cell ER stress and apoptosis. Proc Natl Acad Sci U S A 105(24):8452–8457. https://doi.org/10.1073/pnas.0711232105
28. White SA, Zhang LS, Pasula DJ, Yang YHC, Luciani DS (2020) Bax and Bak jointly control survival and dampen the early unfolded protein response in pancreatic β-cells under glucoli- potoxic stress. Sci Rep 10(1):10986. https://doi.org/10.1038/ s41598-020-67755-3
29. Boutens L, Stienstra R (2016) Adipose tissue macrophages: going off track during obesity. Diabetologia 59(5):879–894. https://doi. org/10.1007/s00125-016-3904-9
30. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G (2010) Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801(3):289–298. https://doi.org/10.1016/j.bbalip. 2009.08.006
31. Sun Y, Qiao L, Xia HH, Lin MC, Zou B, Yuan Y et al (2008) Regulation of XAF1 expression in human colon cancer cell by interferon β: activation by the transcription regulator STAT1. Can- cer Lett 260(1–2):62–71. https://doi.org/10.1016/j.canlet.2007.10. 014
32. Jiang X, Yin L, Zhang N, Han F, Liu WB, Zhang X et al (2018) Bisphenol A induced male germ cell apoptosis via IFNβ-XAF1- XIAP pathway in adult mice. Toxicol Appl Pharmacol 355:247–256. https://doi.org/10.1016/j.taap.2018.07.009
33. Lee MG, Han J, Jeong SI, Her NG, Lee JH, Ha TK et al (2014) XAF1 directs apoptotic switch of p53 signaling through acti- vation of HIPK2 and ZNF313. Proc Natl Acad Sci U S A 111(43):15532–15537. https://doi.org/10.1073/pnas.1411746111
34. Xia Y, Novak R, Lewis J, Duckett CS, Phillips AC (2006) Xaf1 can cooperate with TNFα in the induction of apoptosis, indepen- dently of interaction with XIAP. Mol Cell Biochem 286(1–2):67–76. https://doi.org/10.1007/s11010-005-9094-2
35. Pinto EM, Figueiredo BC, Chen W, Galvao HCR, Formiga MN, Fragoso MCBV et al (2020) XAF1 as a modifier of p53 function and cancer susceptibility. Sci Adv 6(26):eaba3231. https://doi.org/ 10.1126/sciadv.aba3231
36. Plenchette S, Cheung HH, Fong WG, LaCasse EC, Korneluk RG (2007) The role of XAF1 in cancer. Curr Opin Investig Drugs 8(6):469–476
37. Byun DS, Cho K, Ryu BK, Lee MG, Kang MJ, Kim HR et al (2003) Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res 63(21):7068–7075